Before Allison Silvers became vice president of payment and policy at the Center to Advance Palliative Care, she ran an information center that helped the elderly. In both of these roles, she has helped people make the best possible choices after evaluating all of their options.
Before Allison Silvers became vice president of payment and policy at the Center to Advance Palliative Care, she ran an information center that helped the elderly. In both of these roles, she has helped people make the best possible choices after evaluating all of their options.
Transcript (slightly modified)
How have your experiences with community health shaped your work with the Center to Advance Palliative Care?
I spent a number of years running a senior information center where older adults in need would just come in, it was a storefront, and they would need help with housing or social services or finding good care. It was a really good flavor of people not knowing what their options are, and I think that same thing is true for palliative care. People are given a diagnosis, obviously there’s a lot of emotional turmoil that goes with getting diagnoses, and your doctor then informs you of what they recommend.
But typically there’s a whole menu of treatment options, and that’s not adequately communicated, and there’s also a lot of other needs that you have that wouldn’t even be addressed with treatment: spiritual needs, family reconciliation needs, et cetera. So I think that idea of giving people options and helping them think through their options is what’s common.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More